(Q45242454)

11 December 2017

Use of 6-mercaptopurine/azathioprine as the immunomodulator of choice for moderately active Crohn's disease: pro. (English)

1 reference

11 December 2017

1 reference

Jeffrey S Hyams

1

1 reference

11 December 2017

1 February 2005

1 reference

Inflammatory Bowel Diseases

11 December 2017

1 reference

11 December 2017

11

1 reference

11 December 2017

2

1 reference

11 December 2017

197-199

1 reference

Frequency of glucocorticoid resistance and dependency in Crohn's disease

11 December 2017

1 reference

https://api.crossref.org/works/10.1097%2F00054725-200502000-00014

Postoperative outcome of Crohn's disease in 30 children

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F00054725-200502000-00014

Morbidity of juvenile onset inflammatory bowel disease: effects on education and employment in early adult life.

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F00054725-200502000-00014

A controlled double blind study of azathioprine in the management of Crohn's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F00054725-200502000-00014

Endoscopic and histologic healing of Crohn's (ileo-) colitis with azathioprine

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F00054725-200502000-00014

Safety of azathioprine and 6-mercaptopurine in pediatric patients with inflammatory bowel disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F00054725-200502000-00014

Meta-analysis of enteral nutrition as a primary treatment of active crohn's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F00054725-200502000-00014

Glucocorticoid resistance in inflammatory bowel disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F00054725-200502000-00014

Corticosteroid-sparing treatments in patients with Crohn's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F00054725-200502000-00014

Influence of Immunogenicity on the Long-Term Efficacy of Infliximab in Crohn's Disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F00054725-200502000-00014

10.1097/00054725-200502000-00014

21 January 2018

Identifiers

DOI

1 reference

11 December 2017

1 reference

PubMed ID

15677914